| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 51 | 3.944 | 2.563 | 12.571 | 40.305 | 54.245 | 105.688 | 168.357 | 218.550 |
| Total Income - EUR | - | 51 | 3.944 | 2.563 | 12.572 | 40.717 | 54.543 | 105.749 | 169.231 | 219.451 |
| Total Expenses - EUR | - | 47 | 1.113 | 1.491 | 4.673 | 10.443 | 16.641 | 58.035 | 80.075 | 115.405 |
| Gross Profit/Loss - EUR | - | 4 | 2.831 | 1.072 | 7.898 | 30.274 | 37.902 | 47.714 | 89.155 | 104.046 |
| Net Profit/Loss - EUR | - | 1 | 2.712 | 995 | 7.521 | 29.099 | 36.914 | 46.889 | 88.126 | 97.989 |
| Employees | - | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 2 |
Check the financial reports for the company - Neurolog Med Ad Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 84 | 0 | 0 | 575 | 16.253 | 92.989 | 103.937 | 97.292 | 90.454 |
| Current Assets | - | 98 | 2.934 | 3.746 | 7.299 | 19.466 | 38.419 | 32.293 | 64.961 | 63.836 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 1.202 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 72 | 0 | 132 | 28.639 | 54.180 | 57.546 |
| Cash | - | 98 | 2.934 | 3.746 | 7.227 | 19.466 | 37.085 | 3.654 | 10.781 | 6.290 |
| Shareholders Funds | - | 46 | 2.757 | 3.702 | 7.611 | 36.673 | 61.615 | 47.041 | 88.324 | 98.198 |
| Social Capital | - | 45 | 44 | 43 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | - | 137 | 176 | 44 | 263 | 45 | 70.420 | 89.648 | 74.129 | 56.091 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurolog Med Ad Srl